The National Technical Advisory Group on Immunization (NTAGI) on Sunday recommended the Union Ministry of Health to reduce the Covid-19 vaccine Covishield’s duration of the second...
Top doctors and healthcare experts share their inputs and suggestions on the current coronavirus scenario to spread awareness among pandemic-hit people.
Seeing India hit record highs in Covid-19 cases every day has left a lot of people panicking and looking for advice on what to do if...
Planning in advance and ensuring stocks of oxygen, Remdesivir could have prevented such a rise in the number of new cases, say doctors.
Only 0.04% and 0.02% of people receiving Covaxin and Covishield, respectively, contracted Covid-19. Phase 3 trials show Covaxin can neutralise most variants.
Covishield to be sold at Rs 400 a shot to states and Rs 600 a shot to private hospitals.
In a virtual press conference, three senior members of the national Covid-19 task force, Niti Aayog member V.K. Paul, ICMR Director General Balram Bhargava and AIIMS...
In an interview on Monday, AIIMS Director Dr Randeep Guleria briefed the public on the importance of drug management during the ongoing pandemic, which has sparked...
The ongoing coronavirus surge is not really a sudden, one-off incident. About 100 years ago, there was a similar pandemic, healthcare experts tell The Sunday Guardian...
New Delhi: The Centre on Friday said that it is taking steps to boost production of indigenous Covid-19 vaccines, and the production capacity of Bharat Biotech’s...